MedPath

Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over

Not Applicable
Active, not recruiting
Conditions
Soft Tissue Sarcoma Adult
Interventions
Procedure: Geriatric assessment
Registration Number
NCT03077178
Lead Sponsor
Institut Bergonié
Brief Summary

In order to describe functional impact of surgery in elderly patients treated for lower-limb soft-tissue sarcoma, the investigators set up this project which aims to identify prognostic factors among geriatric and functional assessment.

Detailed Description

This is a prospective cohort including 100 patients \> 70 year-old treated by surgery for lower-limb soft-tissue sarcoma. Data on clinical and geriatric characteristics of the patient as well as functional and quality of life assessment will be collected among patient participation (3 years). Primary endpoint is to describe evaluation of the Impact of Locoregional Treatment of Soft Tissue Sarcoma on the Functional Status.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
25
Inclusion Criteria
  1. Aged more than 70 years,
  2. Soft tissue sarcoma histologically proven,
  3. Sarcoma of the soft tissues of the lower limbs,
  4. Operable disease (first-line treatment or neo-adjuvant therapy),
  5. ECOG, Performance Status ≤ 2,
  6. Decision of surgery validated in Multidisciplinary Consultation Meeting,
  7. Reports of the non-opposition documented in the patient file before any procedure specific to the study,
  8. Affiliation to system of Social Security (accordance with article L1121-11 of the Code of Public Health).
Exclusion Criteria
  1. Metastatic disease from the onset or relapse
  2. Participation in another study involving a similar geriatric assessment.
  3. Geographic, familial, social, psychological or psychiatric factors that make the patient incapable of undergoing the study's follow-up and procedures.
  4. Persons deprived of liberty or placed under judicial protection

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Prospective cohortGeriatric assessmentGeriatric assessment
Primary Outcome Measures
NameTimeMethod
Change in Physical functioning assessmentChange from baseline until 36 months after surgery

Quality of life questionnaire QLQ-C30

Secondary Outcome Measures
NameTimeMethod
Surgical complicationsChange from Day 0 until 12 months after surgery

classification Clavien Dindo

OSChange from Day 0 until 36 months after surgery

Overall Survival

Functional status assessment (MST)Change from baseline until 36 months after surgery

Muskuloskeletal Tumor Society (MST) scale

Geriatric parameters assessment - G8baseline

G8 (onco-geratic screening score)

Functional status assessment (TESS)Change from baseline until 36 months after surgery

Toronto Extremity salvage score (TESS) Scale

Geriatric parameters assessment - ADLChange from baseline until 36 months after surgery

ADL (Activities in Daily Living)

Geriatric parameters assessment - IADLChange from baseline until 36 months after surgery

IADL (Instrumental Activities in Daily Living)

Quality of life assessment QLQ-C30Change from baseline until 36 months after surgery

Quality of life questionnaire QLQ-C30

Time until deterioration of physical functioningChange until 36 months after surgery

Quality of life questionnaire QLQ-C30

Geriatric parameters assessment - MNAChange from baseline until 36 months after surgery

MNA (Mini Nutritional Assessment)

Geriatric parameters assessment - GDS 15Change from baseline until 36 months after surgery

GDS 15(Geriatric Depression Scale).

Geriatric parameters assessment - MMSEChange from baseline until 36 months after surgery

MMSE (Mini Mental Status)

Pain AssessmentChange from Baseline until 36 months after surgery

Brief Pain Inventory (BPI) questionnaire

Quality of life assessment QLQ-EDL-14Change from baseline until 36 months after surgery

Quality of life questionnaire QLQ-EDL-14

Geriatric parameters assessment - CIRS-Gbaseline

CIRS-G (Cumulative Illness Rating Scale - Geriatrics)

Trial Locations

Locations (1)

Institut Bergonié

🇫🇷

Bordeaux, France

© Copyright 2025. All Rights Reserved by MedPath